Offline mode

Enzyme immunoassay for the qualitative and quantitative determination of IgG antibodies against SS-A/Ro in human serum or plasma (EDTA, citrate, heparin). SS-A/Ro-antibodies are directed against two distinct proteins, Ro52 and Ro60, which physiologically occur complexed with certain small hY-ribonucleic acids. These antibodies exhibit a high prevalence (> 70%) for the Sjögren-syndrome (SS), an inflammatory autoimmune disorder of the exocrine glands. They are also associated with systemic lupus erythematosus (SLE); especially with some of its variants (e.g. subacute cutane LE: prevalence about 80%). Sometimes, SS-A/Ro-antibodies cannot be detected by immunofluorescence assays (IFA) if the antigen is not sufficiently present in the substrate. Therefore, if SS or SLE is suspected despite negative IFA result, the appropriate enzyme-linked immunosorbent assay (ELISA) could be useful. The majority of SS-A/Ro-positive sera contain antibodies directed at both Ro60 and Ro52; hence, a differentiated analysis would not yield much diagnostic benefit. However, Ro52-specific antibodies seem to be closer related with SS and Ro60- antibodies with SLE.

For concrete data please consult the Instruction for Use in the download box on the top right side.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.